Business, Policy & Funding

FDA Allowed Problematic COVID-19 Tests on the Market Due to Agency's EUA Approach, HHS OIG Finds

Paige, OptraScan Partner to Improve Digital Pathology Integration

PerkinElmer's Oxford Immunotec Gains FDA Go-Ahead for TB Test Automation

Virax Biolabs, Cosmos Holdings Ink Distribution Deal for Monkeypox PCR Test

FDA Urges Work on Monkeypox Assays, Including OTC MDx Tests

Liquid Biopsy Firm Hedera Dx Raises €14M in Seed Funding

Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection

Propath UK, Nucleai Partner on Spatial Proteomics Panel for Immuno-Oncology

BioMérieux, BrightInsight Partner for Clinical Decision Support Solution

Roche Obtains CE Mark for Three Tests on New Cobas PCR Instrument

Foundation Medicine, Day One Biopharmaceuticals to Develop CDx for Tovorafenib

FIND, Curetis Ink R&D Collaboration Agreement

Genome Medical, Pierian Collaborate to Optimize Genomics Programs

Roche Gets FDA 510(k) Clearance for New Cobas Instrument

Epigenomics Expecting Lower Loss in 2022 as It Launches Liquid Biopsy Study

Top Five Articles on 360Dx Last Week: Surprise Billing Law; COVID Tests During Omicron; and More

Qiagen Obtains CE-IVD Mark on NeuMoDx Epstein-Barr Virus, Human Herpesvirus-6 Tests

BioVendor to Distribute Genes2Me IVDs in Czech Republic, Slovakia